← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

XWELL, Inc. (XWEL) 10-Year Financial Performance & Capital Metrics

XWEL • • Industrial / General
Consumer CyclicalPersonal ServicesPersonal Care & Wellness ServicesAirport Wellness & Spa
AboutXWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.Show more
  • Revenue $34M +12.6%
  • EBITDA -$16M +36.1%
  • Net Income -$17M +39.2%
  • EPS (Diluted) -3.66 +44.9%
  • Gross Margin 26.31% +115.2%
  • EBITDA Margin -46.52% +43.2%
  • Operating Margin -49.29% +47.4%
  • Net Margin -49.72% +46.0%
  • ROE -117.39% -45.8%
  • ROIC -66.67% -5.0%
  • Debt/Equity 1.39 +162.9%
  • Interest Coverage -93.34 -6.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Trading at only 0.3x book value
  • ✓Efficient asset utilization: 1.3x turnover

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 5 (bottom 5%)
  • ✗Sales declining 6.9% over 5 years
  • ✗Shares diluted 10.4% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y37.29%
5Y-6.92%
3Y-22.82%
TTM-12.74%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-7.58%

EPS CAGR

10Y-
5Y-
3Y-
TTM6.58%

ROCE

10Y Avg-56.44%
5Y Avg-49.59%
3Y Avg-57.87%
Latest-72.97%

Peer Comparison

Airport Wellness & Spa
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
XWELXWELL, Inc.2.42M0.42-0.1112.58%-51.85%-499.25%1.39
EMSmart Share Global Limited249.1M1.15-10.45-35.97%-8.16%-9.04%0.00

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+22.69M18.97M48.82M50.09M48.52M8.38M73.73M55.94M30.11M33.9M
Revenue Growth %14.92%-0.16%1.57%0.03%-0.03%-0.83%7.79%-0.24%-0.46%0.13%
Cost of Goods Sold+19.35M12.82M39.34M39.45M37.85M11.98M41.38M43.89M26.43M24.98M
COGS % of Revenue0.85%0.68%0.81%0.79%0.78%1.43%0.56%0.78%0.88%0.74%
Gross Profit+3.33M6.16M9.48M10.64M10.66M-3.6M32.34M12.05M3.68M8.92M
Gross Margin %0.15%0.32%0.19%0.21%0.22%-0.43%0.44%0.22%0.12%0.26%
Gross Profit Growth %1.14%0.85%0.54%0.12%0%-1.34%9.99%-0.63%-0.69%1.42%
Operating Expenses+13.68M28.57M24.55M25.74M26.53M36.51M28.24M43.21M31.89M25.63M
OpEx % of Revenue0.6%1.51%0.5%0.51%0.55%4.35%0.38%0.77%1.06%0.76%
Selling, General & Admin10.07M14.11M16.58M16.24M14.32M15.94M24.2M31.17M20.91M20.08M
SG&A % of Revenue0.44%0.74%0.34%0.32%0.3%1.9%0.33%0.56%0.69%0.59%
Research & Development92K681K00000000
R&D % of Revenue0%0.04%--------
Other Operating Expenses0681K-197K498K12.21M20.57M4.04M12.04M10.98M5.54M
Operating Income+-10.34M-22.42M-15.07M-34.73M-15.87M-40.1M4.11M-31.16M-28.21M-16.71M
Operating Margin %-0.46%-1.18%-0.31%-0.69%-0.33%-4.78%0.06%-0.56%-0.94%-0.49%
Operating Income Growth %0.91%-1.17%0.33%-1.3%0.54%-1.53%1.1%-8.59%0.09%0.41%
EBITDA+-6.83M-21.1M-8.23M-25.23M-8.43M-32.88M7.31M-25.73M-24.66M-15.77M
EBITDA Margin %-0.3%-1.11%-0.17%-0.5%-0.17%-3.92%0.1%-0.46%-0.82%-0.47%
EBITDA Growth %0.94%-2.09%0.61%-2.07%0.67%-2.9%1.22%-4.52%0.04%0.36%
D&A (Non-Cash Add-back)3.52M1.32M6.84M9.5M7.44M7.22M3.2M5.43M3.55M938K
EBIT-9.53M-17.58M-15.27M-34.08M-17.78M-24.75M4.94M-24.55M-19.3M-12.1M
Net Interest Income+-2.59M-1.7M-731K-1.83M-2.9M-2.08M0-78K127K201K
Interest Income000001.83M0384K448K380K
Interest Expense2.59M1.7M731K1.83M2.9M1.83M0462K321K179K
Other Income/Expense-1.78M-1.57M-1.28M-1.18M-4.8M-52.12M-1.16M-1.41M212K266K
Pretax Income+-12.12M-24M-16M-35.91M-20.68M-92.22M2.95M-32.57M-27.99M-16.44M
Pretax Margin %-0.53%-1.27%-0.33%-0.72%-0.43%-11%0.04%-0.58%-0.93%-0.49%
Income Tax+-866K13.64M111K-278K-146K7K56K55K35K49K
Effective Tax Rate %0.92%1%1.8%1.04%1.03%0.98%1.14%1.01%0.99%1.03%
Net Income+-11.16M-24.01M-28.84M-37.2M-21.22M-90.49M3.35M-32.84M-27.74M-16.85M
Net Margin %-0.49%-1.27%-0.59%-0.74%-0.44%-10.79%0.05%-0.59%-0.92%-0.5%
Net Income Growth %0.9%-1.15%-0.2%-0.29%0.43%-3.26%1.04%-10.81%0.16%0.39%
Net Income (Continuing)-11.26M-19.28M-16.11M-35.63M-20.53M-92.23M2.89M-32.63M-28.03M-16.49M
Discontinued Operations000-814K000000
Minority Interest04.64M4.96M4.03M3.7M2.56M7.2M8.02M7.97M8.53M
EPS (Diluted)+-1310.43-1899.36-1552.88-1535.68-251.22-41.390.60-6.97-6.64-3.66
EPS Growth %0.91%-0.45%0.18%0.01%0.84%0.84%1.01%-12.62%0.05%0.45%
EPS (Basic)-1310.43-1899.36-1552.88-1535.68-251.22-41.390.60-6.97-6.64-3.66
Diluted Shares Outstanding8.51K12.64K18.57K24.23K81.72K2.23M5.25M4.68M4.18M4.61M
Basic Shares Outstanding8.51K12.64K18.57K24.23K81.72K2.23M5.22M4.68M4.18M4.61M
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+28.28M23.54M16.09M5.76M3.93M91.78M108.98M47.33M26.57M15.34M
Cash & Short-Term Investments24.95M17.91M6.37M3.4M2.18M89.8M105.51M42.19M23.05M11.8M
Cash Only24.95M17.91M6.37M3.4M2.18M89.8M105.51M19.04M8.44M4.55M
Short-Term Investments000000023.15M14.61M7.25M
Accounts Receivable246K449K800K000615K2.86M1.67M1.79M
Days Sales Outstanding3.968.645.98---3.0418.6520.2119.31
Inventory379K2.94M1.16M782K647K657K1.76M1.16M900K501K
Days Inventory Outstanding7.1583.810.757.246.2420.0115.559.6512.437.32
Other Current Assets1.95M8.1M6.55M370K118K186K48K48K55K56K
Total Non-Current Assets+22.25M59.26M49.15M24.82M24.79M11.36M18.29M23.09M12.43M10.02M
Property, Plant & Equipment-207K16.47M15.8M11.79M16.32M7.2M11M11.94M7.11M5.22M
Fixed Asset Turnover-1.15x3.09x4.25x2.97x1.17x6.71x4.68x4.23x6.50x
Goodwill4.86M25.17M19.63M00004.02M1.37M1.39M
Intangible Assets16.48M15.61M11.55M9.17M6.78M870K3.73M4.01M1.35M1.02M
Long-Term Investments207K1.57M2.81M2.48M484K1.77M722K104K50K85K
Other Non-Current Assets916K2.02M2.17M487K1.21M1.52M3.56M3.02M2.54M2.3M
Total Assets+50.53M82.81M65.24M30.58M28.72M103.13M127.27M70.43M38.99M25.35M
Asset Turnover0.45x0.23x0.75x1.64x1.69x0.08x0.58x0.79x0.77x1.34x
Asset Growth %0.35%0.64%-0.21%-0.53%-0.06%2.59%0.23%-0.45%-0.45%-0.35%
Total Current Liabilities+9.21M11.77M12.5M16.66M16.22M13.48M19.83M10.96M9.33M9.22M
Accounts Payable4.28M5.17M3.36M4.54M7.07M2.44M5.54M2.31M1.1M1.61M
Days Payables Outstanding80.68147.2131.1942.0468.1674.3248.8219.2315.1823.56
Short-Term Debt3.11M008.49M03.3M3.58M000
Deferred Revenue (Current)1000K143K01000K279K914K549K339K861K1000K
Other Current Liabilities1.15M4.46M8.06M2.5M2.45M287K4.37M3.14M2.37M3.52M
Current Ratio3.07x2.00x1.29x0.35x0.24x6.81x5.50x4.32x2.85x1.66x
Quick Ratio3.03x1.75x1.20x0.30x0.20x6.76x5.41x4.21x2.75x1.61x
Cash Conversion Cycle-69.58-54.77-14.46----30.229.0817.463.07
Total Non-Current Liabilities+802K6.87M6.9M791K15.04M9.29M7.5M11.52M8.69M8.39M
Long-Term Debt06.5M6.5M05.76M2.35M0000
Capital Lease Obligations00005.83M6.93M7.5M11.52M8.69M8.39M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities802K365K404K791K3.45M00000
Total Liabilities10.02M18.64M19.4M17.45M31.26M22.76M27.33M22.48M18.02M17.61M
Total Debt+3.18M6.5M6.5M8.49M15.26M15.38M13.82M14.11M11.09M10.77M
Net Debt-21.77M-11.41M132K5.08M13.07M-74.42M-91.68M-4.93M2.66M6.22M
Debt / Equity0.08x0.10x0.14x0.65x-0.19x0.14x0.29x0.53x1.39x
Debt / EBITDA------1.89x---
Net Debt / EBITDA-------12.55x---
Interest Coverage-3.99x-13.20x-20.62x-19.01x-5.47x-21.89x--67.45x-87.87x-93.34x
Total Equity+40.52M64.17M45.84M13.13M-2.54M80.37M99.94M47.95M20.97M7.74M
Equity Growth %0.3%0.58%-0.29%-0.71%-1.19%32.69%0.24%-0.52%-0.56%-0.63%
Book Value per Share4758.755077.062468.18542.16-31.0336.0719.0210.245.021.68
Total Shareholders' Equity40.52M59.53M40.88M9.11M-6.24M77.81M92.73M39.93M13M-788K
Common Stock132K183K265K352K52K941K1.01M832K42K53K
Retained Earnings-196.86M-220.87M-249.71M-286.91M-308.14M-398.62M-395.27M-428.11M-455.85M-472.71M
Treasury Stock0000000000
Accumulated OCI0-13K-74K-251K-283K-220K-312K-534K-1.92M-1.96M
Minority Interest04.64M4.96M4.03M3.7M2.56M7.2M8.02M7.97M8.53M

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-2.57M-8.44M-12.17M-6.57M-113K-25.01M14.56M-24.19M-16.07M-11.01M
Operating CF Margin %-0.11%-0.44%-0.25%-0.13%-0%-2.98%0.2%-0.43%-0.53%-0.32%
Operating CF Growth %0.91%-2.28%-0.44%0.46%0.98%-220.35%1.58%-2.66%0.34%0.32%
Net Income-11.26M-24M-16.11M-35.63M-20.53M-92.23M2.89M-32.63M-27.74M-16.49M
Depreciation & Amortization3.52M1.84M7.98M9.5M6.12M7.22M4.92M7.27M3.55M2.27M
Stock-Based Compensation5.06M2.57M2.18M916K335K1.33M2.86M3.87M2.32M893K
Deferred Taxes-866K15.1M-3.47M19.23M4.61M00000
Other Non-Cash Items1.8M-216K26K1.54M4.81M67.03M2.26M7.33M7.72M3.9M
Working Capital Changes-826K-3.74M-2.77M-2.12M4.54M-8.36M1.63M-9.94M-1.92M-1.58M
Change in Receivables0-132K-636K-1.83M00-1.12M-1.83M1.19M-193K
Change in Inventory-146K16K1.35M377K136K-10K-1.11M592K261K399K
Change in Payables378K-2.91M-3.11M-604K3.76M-5.17M6.69M-3.25M-488K387K
Cash from Investing+-104K3.47M-5.4M-1.87M-2.27M-4.35M-5.16M-34.84M5.65M5.89M
Capital Expenditures0-641K-4.71M-3.12M-2.27M-3.97M-4.28M-6.84M-1.91M-1.78M
CapEx % of Revenue-0.03%0.1%0.06%0.05%0.47%0.06%0.12%0.06%0.05%
Acquisitions----------
Investments----------
Other Investing-248K2M-960K335K-178K-380K-3.31M-34.84M-468K-9K
Cash from Financing+11.6M-2.06M6.09M5.64M1.17M117.22M6.35M-27.38M8K1.36M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-218K-50K-497K1.29M-1.71M453K-841K69K30K4K
Net Change in Cash----------
Free Cash Flow+-2.57M-9.08M-16.88M-9.68M-2.39M-29.36M6.97M-31.02M-18.45M-12.8M
FCF Margin %-0.11%-0.48%-0.35%-0.19%-0.05%-3.5%0.09%-0.55%-0.61%-0.38%
FCF Growth %0.91%-2.53%-0.86%0.43%0.75%-11.3%1.24%-5.45%0.41%0.31%
FCF per Share-301.97-718.57-909.11-399.64-29.22-13.181.33-6.63-4.42-2.78
FCF Conversion (FCF/Net Income)0.23x0.35x0.42x0.18x0.01x0.28x4.35x0.74x0.58x0.65x
Interest Paid0000735K187K11K10K00
Taxes Paid0000124K11K055K35K59K

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)-31.12%-45.86%-52.43%-126.17%-400.47%-232.51%3.71%-44.41%-80.5%-117.39%
Return on Invested Capital (ROIC)-45.76%-47.02%-22.9%-81.15%-82.8%-364.87%43.37%-91.17%-63.48%-66.67%
Gross Margin14.7%32.44%19.42%21.25%21.97%-42.91%43.87%21.54%12.23%26.31%
Net Margin-49.18%-126.52%-59.07%-74.27%-43.75%-1079.17%4.54%-58.7%-92.14%-49.72%
Debt / Equity0.08x0.10x0.14x0.65x-0.19x0.14x0.29x0.53x1.39x
Interest Coverage-3.99x-13.20x-20.62x-19.01x-5.47x-21.89x--67.45x-87.87x-93.34x
FCF Conversion0.23x0.35x0.42x0.18x0.01x0.28x4.35x0.74x0.58x0.65x
Revenue Growth1492.07%-16.37%157.32%2.6%-3.15%-82.72%779.3%-24.13%-46.18%12.58%

Revenue by Segment

202220232024
Services18.88M27.05M30.66M
Services Growth-43.27%13.33%
Products1.93M2.77M3.24M
Products Growth-43.32%17.03%
Patient services revenue32.78M250K-
Patient services revenue Growth--99.24%-
Other6K40K-
Other Growth-566.67%-

Revenue by Geography

202220232024
United States52.25M24.94M27.81M
United States Growth--52.26%11.50%
Non-US--6.08M
Non-US Growth---
All other countries3.69M5.17M-
All other countries Growth-40.01%-

Frequently Asked Questions

Growth & Financials

XWELL, Inc. (XWEL) reported $29.5M in revenue for fiscal year 2024. This represents a 4012% increase from $0.7M in 2011.

XWELL, Inc. (XWEL) grew revenue by 12.6% over the past year. This is steady growth.

XWELL, Inc. (XWEL) reported a net loss of $15.3M for fiscal year 2024.

Dividend & Returns

XWELL, Inc. (XWEL) has a return on equity (ROE) of -117.4%. Negative ROE indicates the company is unprofitable.

XWELL, Inc. (XWEL) had negative free cash flow of $15.1M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.